4.6 Article

MMP28 (epilysin) as a novel promoter of invasion and metastasis in gastric cancer

Journal

BMC CANCER
Volume 11, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/1471-2407-11-200

Keywords

-

Categories

Funding

  1. National Key Basic Research Program (NKBRP)
  2. National Natural Science Foundation [30570818, 30600279]
  3. 973 Program [2010CB933902]

Ask authors/readers for more resources

Background: The purpose of this study was to investigate invasion and metastasis related genes in gastric cancer. Methods: The transwell migration assay was used to select a highly invasive sub-line from minimally invasive parent gastric cancer cells, and gene expression was compared using a microarray. MMP28 upregulation was confirmed using qRT-PCR. MMP28 immunohistochemistry was performed in normal and gastric cancer specimens. Invasiveness and tumor formation of stable cells overexpressing MMP28 were tested in vitro and in vivo. Results: MMP28 was overexpressed in the highly invasive sub-cell line. Immunohistochemistry revealed MMP28 expression was markedly increased in gastric carcinoma relative to normal epithelia, and was significantly associated with depth of tumor invasion, lymph node metastasis and poorer overall survival. Ectopic expression of MMP28 indicated MMP28 promoted tumor cell invasion in vitro and increased gastric carcinoma metastasis in vivo. Conclusions: This study indicates MMP28 is frequently overexpressed during progression of gastric carcinoma, and contributes to tumor cell invasion and metastasis. MMP28 may be a novel therapeutic target for prevention and treatment of metastases in gastric cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available